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issection of Long-Range Heart Rate Variability
ontrolled Induction of Prognostic
easures by Activity in the Laboratory
aniel Roach, PHD, Wendy Wilson, AART, Debbie Ritchie, MN, Robert Sheldon, MD, PHD
algary, Alberta, Canada
OBJECTIVES We sought to determine whether the long-range measures of heart rate variability (HRV)—
the standard deviation of sequential 5-min heart period mean values (SDANN) and the heart
period spectral amplitude in the ultra-low frequency band 0.0033 Hz (ULF)—had their
origins partly in physical activity.
BACKGROUND The SDANN and ULF are prognostic HRV factors whose physiologic origins are obscure.
Their discontinuous presence throughout the day suggested that they arise from changes in
heart period due to activity.
METHODS Heart period sequences were recorded from 14 patients with left ventricular dysfunction and
14 control subjects during an unrestricted 24-h day, 4-h supine rest, and 4-h epoch with
scripted activities.
RESULTS The SDANN was higher during activity than during rest (74  23 ms vs. 43  17 ms, p 
0.0001), as were ULF magnitudes (p 0.0001). The increase in SDANN was due to specific
activities that contributed heavily (p  0.0001 by analysis of variance); for example, a 10-min
walk and 90-min rest each contributed 22% of total SDANN. Patients with heart disease had
a lower SDANN and ULF and a higher mean heart rate than control subjects during all
recordings. The proportional ranges in heart period were the same in the two groups during
controlled, scripted activities but were wider in control subjects than in patients during
ambulatory recordings, suggesting decreased activity by patients.
CONCLUSIONS Activity increases SDANN by increasing the range of heart periods. Patients with diminished
ventricular function have a reduced SDANN on ambulatory electrocardiograms, possibly and
partly because of a higher mean heart rate and reduced variations in physical activity. (J Am
Coll Cardiol 2004;43:2271–7) © 2004 by the American College of Cardiology Foundationb
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seasures of long-range heart rate variability (HRV) are
mportant prognostic predictors. They include the standard
eviation of the mean values of successive 5-min heart
eriod epochs (SDANN) and the power in the ultra-low
requency band 0.0033 Hz (ULF). The SDANN corre-
ates well with the log of the ULF power (1). Reductions in
DANN and ULF predict poor survival for patients with
hronic, severe mitral regurgitation (2), acute or recent
yocardial infarction (3–5), and idiopathic dilated cardio-
yopathy (6), as well as for 6,693 outpatients assessed for
rrhythmias (7).
See page 2278
Despite this, their physiologic origins are obscure. Hy-
othesized causes include oscillatory and aperiodic, deter-
inistic changes (8,9), as well as heart period fluctuations
ue to peripheral vasomotor, thermoregulatory, or renin-
ngiotensin systems (10). We have shown in healthy am-
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ouncil, Ottawa, Canada, and from the Calgary General Hospital Research and
evelopment Committee, Calgary, Canada. Dr. Roach was a Postdoctoral Fellow of
he Heart and Stroke Foundation of Canada, Ottawa, Canada.
Manuscript received July 17, 2003; revised manuscript received January 7, 2004,sccepted January 12, 2004.ulatory subjects that SDANN arises from epochs of time
hen patients have local mean heart period values that differ
rom the 24-h mean heart period (i.e., mainly at night) (11).
imilarly, ULF power occurs predominantly when patients
re changing their behavior from passive to active, and vice
ersa. We hypothesized that both SDANN and ULF do not
rise from systemic oscillatory processes; rather, they arise
rom changes in activity levels. Our goals were: 1) to directly
etermine the effect of changes in activity level on SDANN
nd ULF; and 2) to determine the cause of reduced HRV in
atients with left ventricular (LV) dysfunction.
ETHODS
xperimental and analytic approach. The subjects in-
luded patients with poor LV function and healthy people
n the same age range in order to increase the likely range of
RV and to allow a comparison between the two popula-
ions. They underwent three recording sessions on separate
ays. The first was an unrestricted 24-h session to assess
RV during usual daily activities. The second was a 4-h
ession of enforced bed rest to obtain recordings under
akefulness but with a range of restricted activities. An
bserver was present to monitor activities and prevent
leeping. The third was a 4-h session during which the
ubjects followed a script with a range of normal daily
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Long-Range HRV June 16, 2004:2271–7ctivities. The scripted activities began with 10 min of
tanding, followed by 40 min of seated reading, 50 min for
eated lunch, 90 min of supine rest, 10 min for a washroom
isit, 10 min of sitting, 10 min of standing, 10 min of
readmill walking at 1.7 km/h, and finally 10 min of sitting.
hus, the “activity day” provided a controlled range of
hysical activity, and the control “rest day” provided bed
est. The minimum 10-min epochs were selected to be at
east twice the minimum sampling interval of SDANN and
LF.
ubjects. All subjects gave written, informed consent; the
rotocol was approved by the University of Calgary Con-
oint Medical Ethics Review Board. Patients were eligible if
hey had an LV ejection fraction 40%. Exclusion criteria
ncluded limiting orthopedic or vascular disease, drugs that
ight cause chronotropic incompetence, and a permanent
acemaker. Control healthy subjects were in a population
ith the same age range as the patients. During the study,
hree healthy volunteers were found to have significant
oronary artery disease and were released from the study for
reatment; other volunteers replaced them.
ata acquisition. Ambulatory electrocardiographic
ECG) recordings were acquired using a system that uses a
ynchronization pulse to reduce variability due to tape speed
uctuations. The recordings were analyzed using the Mar-
uette 8000 Scanner, with version 5.7 of the Marquette
rrhythmia Analysis Program to identify and label each
RS complex. Entire recordings were analyzed by an
perator to eliminate cycles in which ventricular beats were
ithout normal P waves. These beats were replaced by
inear interpolation between adjacent normal beats. Unclas-
ified beats were corrected manually. No recordings had
ctopy more severe than isolated complexes or couplets. The
orrected sequences were analyzed in MATLAB (The
athworks, Natick, Massachusetts).
ime and frequency domain analyses. For most analyses,
e used SDANN, because it can be calculated in short
ell-defined epochs. The ULF requires much longer se-
uences, and this makes time-frequency analysis difficult. The
DANN was calculated as the standard deviation of the
equence of the mean heart periods of normal beats within
uccessive 300-s epochs. The standard deviation of all heart
eriods (SDNN) was calculated as the standard deviation of
he sequence of all heart periods of normal beats. For power
Abbreviations and Acronyms
ACE  angiotensin-converting enzyme
ANOVA  analysis of variance
ECG  electrocardiogram
HRV  heart rate variability
LV  left ventricular
SDANN  standard deviation of sequential 5-min heart
period mean values
SDNN  standard deviation of all heart periods
ULF  ultra-low frequency band 0.0033 Hzapectral density functions, we first computed a 24-h Fourier
ransformation (11). Using linear interpolation, the 24-h heart
eriod sequences were uniformly sampled 218 times using a
ample interval of 0.329 s. The interpolated sequences had
heir mean values removed, were Hanning windowed, and
hen transformed to the frequency domain using a fast Fourier
ransform. The ULF power is the sum of the power in band
0.0033 Hz, excluding the direct current component, and the
LF magnitude is the sum of the magnitude of the ULF
omponents. Note that the ULF magnitude is ULF power1/2
nd is dimensionally equivalent to SDANN; both are ex-
ressed as milliseconds.
We calculated the contributions of the specific activities
n each 5-min epoch to the total SDANN of the scripted
ctivity day (11). First, we replaced the mean heart period
alue of each successive 300-s epoch with the 4-h mean
eart period and then recalculated the SDANN of this
ltered 4-h sequence. The difference between the original
DANN and the SDANN of the altered sequence is the
ocal SDANN (i.e., the contribution made by that particular
00-s epoch toward total SDANN). Local SDANN values
ere normalized such that their sum equaled the total
DANN.
tatistical analysis. We used the Kolmogorov-Smirnov
est to examine the normality of distributions. Normal
istributions are reported as the mean value  SD. Non-
ormal distributions are reported as 25%, median, and 75%
uartile values. Analysis of variance (ANOVA) was used
or grouped variables of normal distributions, and the
ruskal-Wallis test was used for grouped variables of
on-normal distributions. The unpaired t test was used to
ompare normal distributions, and the Mann-Whitney U
onparametric test was used for comparing non-normal
istributions.
ESULTS
he 14 patients (13 men) with heart disease had a mean
ge of 64  11 years (Table 1). Two had idiopathic
ilated cardiomyopathies and 12 had old myocardial
nfarctions. Their mean LV ejection fraction was 29 
%. None were taking beta-blockers, verapamil, dilti-
zem, or amiodarone. Their mean New York Heart
ssociation functional class was 1.7  0.6. Medications
sed included diuretics (n  12), angiotensin-converting
nzyme (ACE) inhibitors (n  11), nitrates (n  7),
igoxin (n  3), and apresoline (n  2). None had
edications held or discontinued to participate in the
tudy. There were 14 control subjects (age 66  7 years,
women). None were taking medications. All subjects
ompleted the protocol.
eart period sequences and HRV. The patient and con-
rol recordings were generally similar (Fig. 1). Both showed
iurnal fluctuations in heart period for the 24-h recordings,
ith similarly distributed changes in heart period during thectivity day and relatively little variation in heart period
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June 16, 2004:2271–7 Long-Range HRVuring the rest day. Patients had a lower mean heart period
han did controls (Table 2) during each of the three sessions
p  0.0002). The SDNN, the measure of total variation in
eart period sequences, was lower in patients than in
ontrols in all three sessions (p  0.0009 to 0.01) and was
able 1. Summary Characteristics of Control Subjects and Patien
Subject No.
Controls
Age (yrs) Gender Age (yrs)
1 51 F 39
2 60 F 49
3 60 M 50
4 61 F 57
5 63 M 62
6 64 M 67
7 64 M 69
8 66 M 70
9 66 M 70
10 67 M 72
11 71 F 73
12 72 F 73
13 74 M 73
14 79 M 78
Summary 66  7* 5 F/9 M 64  11*
Expressed as mean value  SD.
CAD  coronary artery disease with old myocardial infarction; F  female; ID
raction; M  male; NYHA  New York Heart Association.
igure 1. Heart period recordings. (Top panels) Recordings from a 24-h d
ecordings from a 4-h scripted activity day from the same subjects. (Bottotandard deviation of sequential 5-min heart period mean values. ULFmag  Uigher on scripted activity days than scripted rest days (p 
. 0013 to 0.0036).
In the total population, the SDANN was higher during
cripted activity days than during rest days (74  23 ms vs.
3  17 ms, p  0.0001). This effect was noted separately
Patients
Gender Etiology LVEF (%) NYHA Class
M CAD 19 I
M IDCM 12 I
M CAD 35 I
M CAD 36 II
F CAD 25 II
M CAD 24 II
M CAD 28 II
M CAD 37 II
M IDCM 37 III
M CAD 38 I
M CAD 27 II
M CAD 20 II
M CAD 28 I
M CAD 30 II
1 F/13 M 29  8* 1.7  0.6*
idiopathic nonischemic dilated cardiomyopathy; LVEF  left ventricular ejection
m a control subject (left) and heart failure patient (right). (Middle panels)
nels) Recordings from a 4-h rest day from the same subjects. SDANN ts
CM ay fro
m paLF magnitude.
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Long-Range HRV June 16, 2004:2271–7or both patients (63  25 ms vs. 37  19 ms, p  0.005)
nd control subjects (84  14 ms vs. 50  12 ms, p 
.0001). In the total population, the ULF magnitude was
igher during scripted activity days than during rest days (71
29 ms vs. 38 14 ms, p 0.0001). This effect was noted
eparately for both patients (63  34 ms vs. 34  15 ms, p
0.0067) and control subjects (80 22 ms vs. 42 13 ms,
 0.0001). Finally, the SDANN and ULF magnitude
orrelated well with each other within each type of record-
ng session (24-h day, R2  0.92; scripted rest, R2  0.60;
cripted activity, R2  0.89; p  0.0001 for each). In
ummary, scripted physical activities increase the SDANN
nd ULF magnitude more than that which occurs during
nforced rest.
ontribution of specific activities to SDANN. We pre-
icted that the induction of specific activities would be
ccompanied temporally by changes in SDANN. Numerous
ocal contributions to SDANN were scattered throughout
he recording period, particularly at times of maximal local
eviation of the heart period from the global mean value
Fig. 2). Specific events contributed heavily (p  0.0001 by
NOVA) to total SDANN (Table 3). For example, a
0-min walk and 90-min rest each contributed 22% of total
DANN. Although the mean contribution per 5-min
poch was 1.61 ms, the intensity of the localized SDANN
ontribution per 5-min epoch was highly localized (p 
.0001 by ANOVA). For example, a 90-min supine rest and
0-min treadmill walk contributed 1.2 ms/5 min and 8.0
s/5 min, respectively. Thus, specific physical activities
ontribute localized and idiosyncratic proportions of overall
Table 2. Heart Period Sequences and Heart R
Recording Periods*
24-h Day
Mean heart period (ms)
Total subjects 867  135
Patients‡ 775  69
Controls 952  127 1
Patients vs. controls, p value 0.0002
SDNN (ms)
Total subjects 140  61
Patients‡ 102  50
Controls 175  51
Patients vs. controls, p value 0.0009
SDANN (ms)
Total subjects 125  56
Patients‡ 92  47
Controls 154  47
Patients vs. controls, p value 0.002
ULF magnitude (ms)
Total subjects 123  59
Patients 93  51
Controls 154  52
Patients vs. controls, p value 0.0047
*As depicted in Figure 1. ‡Patients with reduced ventricular
versus controls, and paired t tests were used to compare rest
N/A  not applicable; SDANN  standard deviation o
deviation of all heart periods; ULF  ultra-low-frequency bDANN. 5ources of reduced heart period variability in patients.
e wished to determine whether (and why) induced
DANN and ULF were lower in the patients with heart
isease (Table 2). The SDANN was lower in patients than
n controls during their daily activities (92  47 ms vs. 154
47 ms, p  0.002), and the ULF magnitude was lower in
atients than in controls during their daily activities (93 
1 ms vs. 154  52 ms, p  0.0047). Similarly, the
ariability During the Three
pted
Day
Scripted Activity
Day
Rest vs. Activity
p Value
 184 847  137 0.0001
 116 760  105 0.0001
 130 933  107 0.0009
001 0.0002 N/A
 28 93  34 0.0001
 28 81  43 0.0036
 20 105  17 0.0013
10 0.0065 N/A
 17 74  23 0.0001
 19 63  25 0.005
 12 84  14 0.0001
49 0.013 N/A
 14 71  29 0.0001
 15 63  34 0.0067
 13 80  22 0.0001
13 0.066 N/A
ic function. Unpaired t tests were used to compare patients
activity. Data are presented as the mean value  SD.
ential 5-min heart period mean values; SDNN  standard
0.0033.
igure 2. Temporally localized contributions to standard deviation of
equential 5-min heart period mean values (SDANN) due to scripted
ctivities. (Top panel) Heart period recordings from a control subject and
atient during a scripted activity day. (Bottom panel) Contribution perate V
Scri
Rest
952
816
,088
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systol
versus
f sequ-min epoch of each activity in each subject to overall SDANN.
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June 16, 2004:2271–7 Long-Range HRVDANN was lower in patients than in controls during
cripted activity days (37  19 ms vs. 50  12 ms, p 
.049) and scripted rest days (63  25 ms vs. 84  14 ms,
 0.013). Similar directional differences in ULF tended
oward significance. Therefore, patients had a lower
DANN (and possibly a lower ULF magnitude) than did
ontrol subjects in all recordings.
This protocol provides a preliminary insight into the
auses of the differences in these measures of HRV between
atients and control subjects. The SDANN is a standard
eviation and therefore is the product of the mean heart
eriod and the dimensionless coefficient of variation. The
ean heart period reflects the global averaged heart period
esponse to activities during the recording session. The
oefficient of variation reflects the range of responses of
eart period to the range of physical activities. Is SDANN
ower in patients because the mean heart period is lower, or
ecause the coefficient of variation is lower?
We first determined whether the differences in SDANN
etween patients and controls were associated with differ-
nces in the mean heart periods or the coefficients of
ariation under controlled conditions (Table 4). During the
cripted rest day, patients and controls had similar coeffi-
ients of variation (0.042  0.017 vs. 0.042  0.014), but
atients had lower mean heart periods (816  116 ms vs.
,088 130 ms, p 0.0001). Similarly, during the scripted
able 3. Contributions of Each of the Specific Activities
uring the Scripted Activity Day Depicted in Figure 3 to the
otal SDANN*
Activity
Duration
(min)
SDANN
Contribution (ms)
SDANN
Contribution
(ms/5 min)
tand, talk 10 3.1  4.0 (4.1%) 1.6
it, read 40 7.6  9.5 (10.2%) 0.9
unch 50 15.4  10.3 (20.8%) 1.5
upine read 90 22.0  14.6 (29.7%) 1.2
ashroom 10 3.9  3.0 (5.3%) 1.9
it 10 1.2  1.9 (1.6%) 0.6
tand 10 2.0  2.2 (2.7%) 1.0
readmill 10 16.1  10.4 (21.8%) 8.0
it 10 3.2  3.4 (4.3%) 1.6
Expressed as absolute contribution and as contribution per 5-min epoch. The
ercentages represent total SDANN contributed by each particular activity.
SDANN  standard deviation of sequential 5-min heart period mean values.
able 4. Contributions of Mean Heart Period and Coefficient of
24-h Day
ean heart period
Patients 775  69
Controls 952  127
Patients vs. controls, p value 0.0002
oefficient of variation
Patients 0.116  0.055
Controls 0.162  0.045
Patients vs. controls, p value 0.025
ata are expressed as the mean value  SD.
Abbreviations as in Table 2.ctivity day, patients and controls had similar coefficients of
ariation (0.085  0.031 vs. 0.089  0.015), but patients
ad lower mean heart periods (760 105 ms vs. 933 107
s, p  0.0002). Therefore, under controlled conditions,
he lower SDANN of patients is associated with a lower
ean heart period, and not a lower coefficient of variation,
hus, in turn, a surrogate measure of the range of activities.
n contrast, during the unrestricted 24-h day, patients had
oth lower mean heart periods (775  69 ms vs. 952  127
s, p 0.0002) and lower coefficients of variation (0.116
.055 vs. 0.162  0.045, p  0.025) than did control
ubjects. Therefore, during unrestricted activities, patients
ave a lower SDANN that is associated with both a higher
ean heart rate and possibly a reduced range of physical
ctivities.
ISCUSSION
revious reports suggested that long-range HRV might
rise in the renin-angiotensin system or in thermoregula-
ion. In three conscious dogs, ACE inhibition increased
ower 2.5- to 4-fold in a bandwidth 0.1 Hz (12).
imilarly, captopril increased SDANN by 27% to 35% in
atients within a week of acute myocardial infarction (13) or
ith mild-to-moderate heart failure (14). The mechanism
f this effect might be due to bradykinin, renin, angiotensin,
r peripheral vasomotor tone (15). A second and untested
ource is thermoregulation. Thermoregulatory skin blood
ow fluctuations might be reflected in blood pressure
uctuations and, in turn, transduced by arterial barorecep-
ors into heart period fluctuations (16).
These uncertainties lead us to search for temporally
ocalized origins of SDANN and ULF on 24-h ambulatory
CGs of healthy subjects. The local contributions to the
ignals were discontinuous, with SDANN predominantly
rising during sleep (when the heart period is furthest from
he 24-h mean heart period) and ULF predominantly
rising during the transitions to and from sleep (when the
argest and most persistent heart period changes occur [11]).
he apparent origin of SDANN from sleep may be ex-
lained on theoretical grounds. The SDANN is the sum of
he squares of the differences between the temporally local
ean heart periods and the global mean heart period, and
ation to the Reduced SDANN in Patients With Heart Disease
odel Rest
Day
Model Activity
Day
Rest vs. Activity
p Value
6  116 760  105 0.0001
8  130 933  107 0.0009
0.0001 0.0002 N/A
2  0.017 0.085  0.031 0.001
2  0.014 0.089  0.015 0.001
0.97 0.72 N/AVari
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Long-Range HRV June 16, 2004:2271–7ecause people spend only a minority of the 24-h day asleep,
he mean heart rate at this time will be further from the
ean than the mean heart rate at other times (11). We used
caled wavelets to show that ULF mainly detected one-way
onharmonic variations in heart rate around times of arising
nd going to bed.
rigins of SDANN and ULF in physical activities. Here
e report that SDANN and ULF are induced under
ontrolled conditions with a protocol that included a range
f physical activities, and that SDANN arises discontinu-
usly during the activity protocol. It is not physical activity,
er se, that causes long-range HRV; rather, it is the range of
hysical activities, each with their own metabolic and
emodynamic demands and with their own mean heart
ates, which is reflected in a corresponding range of heart
ates and therefore heart rate variabilities. The importance
f activity was highlighted by the demonstration that
DANN and ULF could be induced with activity-
esponsive pacemakers in levels very similar to those induced
y pacemakers that tracked sinus node activity (17). There is
covariant relationship between HRV and body movement
18), and heart period variance and the power in the
requency band of 0.0033 to 0.033 ms are higher on exercise
ecordings than on rest recordings (19). Therefore increas-
ng the range of physical activities increases SDANN, and
oes so by increasing the range of heart periods.
The SDNN and SDANN are related measures. Both are
tandard deviations; SDANN reflects the distribution of the
ean heart period of sequences 5 min long, whereas SDNN
eflects the distribution of all heart periods. The SDANN
herefore reflects changes that take place over long periods
f time, whereas SDNN reflects all changes in heart period.
he SDNN behaves much like SDANN, suggesting that
uch of it may arise similarly.
linical implications. Mean heart periods were lower and
ncreases in SDANN and ULF were smaller in patients
ith poor ventricular function than in control subjects.
hen the activity range was controlled, the coefficient of
ariation was similar in patients and controls, suggesting
hat patients might have less ranges of activity than controls
n the 24-h recordings. Taken together, the data suggest
hat SDANN and ULF may be surrogate measures for two
mportant factors: mean heart rate and range of physical
ctivity. The latter raises the possibility that SDANN and
LF may be measures of functional capacity. Measuring the
unctional capacity of patients provides useful information
n their clinical status and prognosis and is commonly
ssessed with techniques such as the 6-min walk (20).
A simple assessment of functional status, based on daily
ctivities in the community rather than in the clinic, might
e helpful. However, Table 4 shows that the reduction in
DANN and ULF in patients is associated with both a
igher mean heart rate and lower coefficient of variation.
ndeed, the usefulness of SDANN and ULF might arise
ecause they reflect both the mean heart rate, which is itself
prognostic measure (21,22), and the coefficient of varia-ion, which may reflect functional capacity. Those patients
ho have a high heart rate and/or are inactive, either by
hoice or because they are too ill, will have a reduced
ong-range HRV, and each factor portends a poor prognosis
ompared with more active patients.
This study illustrates a difficulty with conventional long-
ange estimates of HRV. Obtaining an ambulatory ECG
ecording is equivalent to performing an uncontrolled ex-
eriment, with each recording being an idiosyncratic mix of
ubject-driven physical activity and mean heart rate. The
atter might be influenced by drugs that affect the sinus
ode, such as beta-blockers (23), calcium channel antago-
ists (24), antimuscarinic agents (25), and amiodarone (26).
lso, subjects with high heart rates or those confined to bed
or reasons other than functional capacity and volition may
ave misleadingly low SDANN and ULF values.
onceptual implications. This study illustrates an events-
ased conceptual and methodologic framework for under-
tanding and possibly modifying HRV (27–30). This ap-
roach focuses on the individual responses of the sinus node
o transient physiologic stresses and does not assume any
lobal properties; rather, it focuses on temporally localized
tructures within the recordings and overcomes the problem
f stationarity that confounds frequency domain analyses.
e named this a lexical approach, with each of the distinct
tructures being termed a “lexon,” in that these structures
eem to be arranged like words in a sentence. This approach
dentified the burst, a transient tachycardia induced by
xercise initiation (27,28); an abrupt, large-magnitude, tran-
ient bradycardia that occurs in both humans and in
onscious rabbits (29); the controlled induction of heart rate
urbulence (30); and the discontinuous and physiologic
rigin of SDANN and ULF (11,17).
tudy limitations. Our patients were not completely drug
ree. However, none were receiving drugs with substantial
ffects on the sinus node (23–26). Many were taking ACE
nhibitors, but these drugs increase rather than decrease
RV (13–15). We did not compare the number of meta-
olic equivalents performed by patients and control subjects
uring their typical days; instead, we elected to measure the
esponse of HRV to a uniform amount of activity. We
ocused our study on long-range measures of HRV, and
DNN was included as a global measure of all ranges of
RV. We have not performed similar calculations for the
requency bandwidths centered on 0.10 or 0.25 Hz or their
ime domain equivalents, because we would expect to find
hem different between rest and activity days. They are
ensitive to posture, which is different between the two
cripted days, but this does not address our primary
ypothesis.
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